ObvioHealth is at Life Science Innovation Northwest 2023

Attending Life Science Innovation Northwest this year? We’ll be there! And, we’re excited for the opportunity to chat about optimizing patient-centric clinical trials—with best-in-class digital tools that drive efficiency and generate stronger evidence.

Schedule a Meeting

Panel Discussion: Must clinical trials be so costly?

Let’s talk digital transformation! Learn how the right use of remote technologies can reduce clinical trial recruitment costs by casting a wider net and retaining more patients in studies. All this while also reducing site burden and enhancing data accuracy.

Scott Dixon

Chief Commercial Officer at ObvioHealth

Brian Finrow

CEO and Co-Founder at Lumen Bioscience

Tanya Chiatovich

Senior Director of Business Operations and Research Administration at Fred Hutchinson Cancer Center

Theresa Deisher, PhD

President and CSO at AVM Biotechnology

About ObvioHealth

ObvioHealth is an end-to-end virtual research organization (VRO) combining the clinical excellence of the best CROs with pioneering technology. Powered by these three key differentiating capabilities, we optimize clinical trials at every stage and touchpoint—streamlining the process for patients, sites, and sponsors alike.  

  • ObvioGo® DCT platform and app incorporates best-in-class digital instruments, AI, and machine learning to deliver more robust clinical outcomes with less burden on all stakeholders.
  • Virtual site team monitors patient safety and compliance in real time while providing on-demand, personalized support that keeps patients motivated and engaged.
  • DCT strategists leverage deep clinical expertise and 6+ years of DCT experience to offer the same services as a traditional CRO—but optimized for a decentralized environment.